Gene therapy with neurogenin 3 and betacellulin reverses major metabolic problems in insulin-deficient diabetic mice

Endocrinology

Volumn 150, Issue 11, 2009, Pages 4863-4873

  Yechoor, Vijay ^a   Liu, Victoria ^a   Paul, Antoni ^a,b   Lee, Jeongkyung ^a   Buras, Eric ^a   Ozer, Kerem ^a   Samson, Susan ^a   Chan, Lawrence ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETACELLULIN; GLUCOSE; GLYCOGEN; INSULIN; KETONE BODY; NEUROGENIN 3; TRANSCRIPTOME;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; CELL GRANULE; CONTROLLED STUDY; DRUG RESPONSE; GENETIC TRANSCRIPTION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLYCOGEN LIVER LEVEL; HYPERGLYCEMIA; INSULIN DEFICIENCY; INSULIN RELEASE; KETONEMIA; LIPID METABOLISM; LIPOGENESIS; MOUSE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE THERAPY; HUMANS; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISLETS OF LANGERHANS; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS;

EID: 70350310094     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0527     Document Type: Article

References (22)

1. Thulé PM, Liu JM 2000 Regulated hepatic insulin gene therapy of STZ-diabetic rats. Gene Ther 7:1744-1752
2. Olson DE, Paveglio SA, Huey PU, Porter MH, Thulé PM 2003 Glucose-responsive hepatic insulin gene therapy of spontaneously diabetic BB/Wor rats. Hum Gene Ther 14:1401-1413
3. Kozlowski M, Olson DE, Rubin J, Lyszkowicz D, Campbell A, Thulé PM 2007 Adeno-associated viral delivery of a metabolically regulated insulin transgene to hepatocytes. Mol Cell Endocrinol 273:6-15 (Pubitemid 47016742)
4. Olson DE, Thulé PM 2008 Gene transfer to induce insulin production for the treatment of diabetes mellitus. Expert Opin Drug Deliv 5:967-977
5. Jensen MV, Joseph JW, Ronnebaum SM, Burgess SC, Sherry AD, Newgard CB 2008 Metabolic cycling in control of glucose-stimulated insulin secretion. Am J Physiol Endocrinol Metab 295:E1287-E1297
6. Olson DE, Campbell AG, Porter MH, Freeman KG, Kelso E, Flatt WP, Thulé PM 2008 Hepatic insulin gene therapy normalizes diurnal fluctuation of oxidative metabolism in diabetic BB/Wor rats. Mol Ther 16:1235-1242 (Pubitemid 351866054)
7. Porter MH, Paveglio SA, Zhang JA, Olson DE, Campbell AG, Thulé PM 2005 Host cells reduce glucose uptake and glycogen deposition in response to hepatic insulin gene therapy. J Invest Med 53:201-212
8. Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, Cagliero E, Alejandro R, Ryan EA, DiMercurio B, Morel P, Polonsky KS, Reems JA, Bretzel RG, Bertuzzi F, Froud T, Kandaswamy R, Sutherland DE, Eisenbarth G, Segal M, Preiksaitis J, Korbutt GS, Barton FB, Viviano L, Seyfert-Margolis V, Bluestone J, Lakey JR 2006 International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355:1318-1330 (Pubitemid 44465460)
9. Huang X, Moore DJ, Ketchum RJ, Nunemaker CS, Kovatchev B, McCall AL, Brayman KL 2008 Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation. Endocr Rev 29:603-630
10. Yechoor V, Chan L 2005 Gene therapy progress and prospects: gene therapy for diabetes mellitus. Gene Ther 12:101-107 (Pubitemid 40185913)
11. Samson SL, Chan L 2006 Gene therapy for diabetes: reinventing the islet. Trends Endocrinol Metab 17:92-100
12. Yechoor V, Liu V, Espiritu C, Paul A, Oka K, Kojima H, Chan L 2009 Neurogenin3 is sufficient for transdetermination of hepatic progenitor cells into neo-islets in vivo but not transdifferentiation of hepatocytes. Dev Cell 16:358-373
13. Ng P, Parks RJ, Cummings DT, Evelegh CM, Sankar U, Graham FL 1999 A high-efficiency Cre/loxP-based system for construction of adenoviral vectors. Hum Gene Ther 10:2667-2672
14. Hara M, Wang X, Kawamura T, Bindokas VP, Dizon RF, Alcoser SY, Magnuson MA, Bell GI 2003 Transgenic mice with green fluorescent protein-labeled pancreatic β-cells. Am J Physiol Endocrinol Metab 284:E177-E183 (Pubitemid 36082810)
15. Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M, Sturn A, Snuffin M, Rezantsev A, Popov D, Ryltsov A, Kostukovich E, Borisovsky I, Liu Z, Vinsavich A, Trush V, Quackenbush J 2003 TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34:374-378 (Pubitemid 36184095)
16. Tusher VG, Tibshirani R, Chu G 2001 Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121 (Pubitemid 32397092)
17. Itoh Y, Kawamata Y, Harada M, Kobayashi M, Fujii R, Fukusumi S, Ogi K, Hosoya M, Tanaka Y, Uejima H, Tanaka H, Maruyama M, Satoh R, Okubo S, Kizawa H, Komatsu H, Matsumura F, Noguchi Y, Shinohara T, Hinuma S, Fujisawa Y, Fujino M 2003 Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40. Nature 422:173-176 (Pubitemid 36362750)
18. Itoh Y, Hinuma S 2005 GPR40, a free fatty acid receptor on pancreatic β cells, regulates insulin secretion. Hepatol Res 33:171-173 (Pubitemid 41799798)
19. McGarry JD 1992 What if Minkowski had been ageusic? An alternative angle on diabetes. Science 258:766-770
20. McGarry JD 2002 Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51:7-18
21. Gangaram-Panday ST, Faas MM, de Vos P 2007 Toward stem-cell therapy in the endocrine pancreas. Trends Mol Med 13:164-173 (Pubitemid 46509744)
22. Halban PA, Kahn SE, Lernmark A, Rhodes CJ 2001 Gene and cell-replacement therapy in the treatment of type 1 diabetes: how high must the standards be set? Diabetes 50:2181-2191